Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Europe Colorectal Cancer Screening and Diagnostic Market: Analysis and Forecast, 2023-2033
... and is expected to reach $7.30 billion by 2033, growing at a CAGR of 5.72% during the forecast period 2023-2033. The colorectal cancer screening and diagnostic sector are influenced by various factors such as the ... Read More
-
Cytotoxic Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Route of Administration; By Application (Lung Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032
... 2032 The global Cytotoxic Drugs market size is expected to reach USD 20.80 billion by 2032, according to a new study by Polaris Market Research. The report “Cytotoxic Drugs Market Share, Size, Trends, Industry Analysis ... Read More
-
Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033
... CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased ... Read More
-
Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032
... million in 2023 and is anticipated to reach $1,779.4 million by 2032. The anticipated growth in the next-generation breast cancer diagnostic and screening market is projected to be fueled by several factors. These include the ... Read More
-
Acute Myeloid Leukemia Global Market Report 2024
... DC Regimen; AVD Regimen; VCD Regimen4) By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; ClinicsCovering: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation) Acute Myeloid Leukemia Global Market Report ... Read More
-
Global Vaccine Adjuvants Market Size study&Forecast, byType (Pathogen, Adjuvant emulsion, Particulate, Combination, Others), by Application (Infectious diseases, Cancer, Others), by Administration (Oral, Intradermal, Intranasal, Intramuscular, Others) and Regional Analysis, 2023-2030
... valued at approximately USD1.62 billion in 2022 andis anticipated to grow with a healthy growth rate of more than 2.3%duringthe forecast period 2023-2030.Adjuvants are the ingredients that are added to the vaccinations to increase effectiveness ... Read More
-
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024
... - Global Clinical Trials Review, 2024 provides an overview of Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical ... Read More
-
Ewing Sarcoma - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
... (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Tumor Ablation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 10.10% during the forecast period (2024-2029). Key Highlights The COVID-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many healthcare facilities, ... Read More
-
Community Oncology Services Global Market Report 2024
... Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer 3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology Covering: The US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology ... Read More
-
Cancer Monoclonal Antibodies Global Market Report 2024
... Cancer 3) By End-User: Hospitals; Research Laboratories Covering: F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Bristol Myers Squibb Company; Johnson & Johnson; Amgen Inc. Cancer Monoclonal Antibodies Global Market Report 2024 from The Business ... Read More
-
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
... 2020). NSCLC begins when healthy cells that make up the lining of the lungs change and grow out of control, forming a tumor. NSCLC can begin anywhere in the lungs and can be categorized into ... Read More
-
Global AI in Cancer Diagnostics Market (2023-2028) by Components, Cancer Type, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
... 147.61 Mn in 2023 and is expected to reach USD 400.91 Mn by 2028 growing at a CAGR of 22.12%. Market dynamics, which refers to the ever-changing and evolving conditions, trends, and forces that impact ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2024
... Surgical Centers; Multispecialty Clinics; Cancer Research Centers; Cancer Rehabilitation CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG Chemotherapy-Induced Anemia Global Market Report 2024 from The Business Research ... Read More
-
Cervical Cancer Vaccine Global Market Report 2024
... Johnson & Johnson; Merck & Co Inc.; Novartis AG; Sanofi Pasteur Cervical Cancer Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
... to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Penile Cancer Global Market Report 2024
... Radiation Therapy; Chemotherapy; Biological Therapy; Surgery3) By Diagnostic Test: Biopsy; Ultrasound; Imaging Tests4) By Application: Hospital; ClinicsCovering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company; Fresenius Kabi AG Penile Cancer Global Market ... Read More
-
North America Cancer Biopsy Market, By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsy, Surgical Biopsy, Liquid Biopsy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancers, Others (Including Liver Cancer, Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 North America Cancer Biopsy Market Size Set Expands at Significant CAGR of ... Read More
-
Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032
... and New Zealand cutaneous T-cell lymphoma market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, driven by the increasing prevalence of the condition and the development of ... Read More
-
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]) Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031
... Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical)—Global Forecast to 2031. The Europe cancer diagnostics market is projected ... Read More
-
Artificial Intelligence In Oncology Global Market Report 2024
... Tumor4) By Application: Cancer Detection; Drug Discovery; Drug Development5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research InstitutesCovering: Azra AI; IBM Corporation; Siemens Healthcare GmbH; Intel Corporation; GE HealthCare Artificial Intelligence In Oncology Global Market ... Read More
-
Colorectal Cancer Molecular Diagnostics Global Market Report 2024
... Amplification Technology (INAAT)3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare SettingsCovering: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company Colorectal Cancer Molecular Diagnostics Global Market Report 2024 ... Read More
-
Ovarian Cancer Opportunity Assessment and Forecast
... by market for Ovarian Cancer. These sales forecasts leverage data on pharmaceutical sales and drug availability from GlobalData’s World Markets Healthcare (WMH) and POLI Price Intelligence databases. Ovarian Cancer is one of the most lethal ... Read More
-
Global Cancer Profiling Market Assessment, By Biomarker Type [Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers], By Technology [Immunoassays, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Microarray, Spectroscopic Method, Others], By Cancer Type [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Other Cancer], By Application [Clinical Application, Research Application], By End-user [Hospital Associated Diagnostic Laboratories, Diagnostic Centers, Cancer Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
... Cancer Type [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Other Cancer], By Application [Clinical Application, Research Application], By End-user [Hospital Associated Diagnostic Laboratories, Diagnostic Centers, ... Read More
Research Assistance
